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MEN 2A: Update on the Northern Ireland and Australian FamDy 
Patrick J. Morrison,* David R. Hadden,* Colin J. Russell,* and Norman C. Nevin* 
The Northern Irelandl Australian family with mulliple endocrine neoplasia lype 2A (MEN 2A) 
originally described in 1987 is presented with a revised and enlarged pedigree. Four members of the 
first generation studied have died. A seventh member of the second generation studied has developed 
medullary thyroid carcinoma and has progressed to surgery. None oflhe third generation members 
studied has shown any conclusive abnormality in metabolic screening lests. Each member of the third 
and fourth generations has had genetic counseling and (if appropriate) DNA analysis wilh gene 
probes close lo the MEN 2A gene locus on chromosome 10. All members ofthis highly penetrant family 
have remained asymptomatic for their disease. (Henry Ford Hosp Med J 1989:37:127-8) 
Medullary thyroid carcinoma (MTC) in association with pheochromocytoma was originally described by Sipple (1) 
with the hereditary nature being recognized by Cushman (2). 
Since the first two workshops on multiple endocrine neo-
plasia type 2 (MEN 2) in 1984 and 1986, the gene for MEN 2A 
has been localized to chromosome 10. Alt reports of MEN 2A 
show autosomal dominant inheritance with a high degree of 
penetrance. 
The G-kindred, originally described in 1987 (3), have been 
living in County Antrim, Northem Ireland, for many genera-
tions. Several members emigrated to Australia in their youth, 
producing three Austratian branches of the pedigree. Initiat 
screening using basal unstimulated plasma calcitonin (CT) and 
24-hour urinary catecholamines, followed by adrenal computed 
tomography and '"1 meta-iodo-benzylguanidine imaging pro-
duced positive resutts in some members of the famity. We have 
updated these resutts and have used both pentagastrin stimula-
tion CT tests and DNA gene probe anatysis to obtain further in-
formation in patients whose initially described tests were either 
uninformative or inappropriate. The updated pedigree is shown 
in the Figure. 
Updated Case Reports 
Patients' ages reported are as of 1988. 
Case 1-3; This patient, initially thought to be deceased, was 
discovered to be alive and healthy at age 88. She remains 
clinically euthyroid and asymptomatic. Blood has been taken 
for DNA anatysis. 
Case II-1; This patient, the index case, died in 1972. We hope 
to use histologic tissue for DNA extraction to aid pedigree 
anatysis. 
Cases II-2 and II-6; Both remain welt after thyroid surgery. 
Blood has been taken for DNA analysis. 
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Cases II-3, II-4, II-5; These three Australian brothers alt died 
of MTC, 
Case II-7; This member is apparently asymptomatic and has 
refused metabolic and genetic screening. The thyroid gland was 
not palpable. 
Cases I l l - t , i n -2 , m - 4 , nt-5,111-12; A f i remain cfinicalty 
asymptomatic. CT basal levels remain unchanged. Blood has 
been taken for DNA anatysis. 
Cases III-3, III-6, III-8, Il l-tO, I l l - I t , UM4; Att are welt fot-
lowing surgery for MTC. Blood has been taken for DNA anaty-
sis, but atl have refused pentagastrin tests. 
Case III-9; This member is clinically asymptomatic. Pen-
tagastrin tests using the intravenous technique as described by 
Telenius-Berg et at (4) resulted in undetectable CT before and 
after stimulation. 
Case 111-13; This member is clinically asymptomatic. Pen-
<0.02 p-g/L basal and 
0.03 |JLg/L at two minutes. Blood has been taken for DNA 
analysis. 
Case 111-15; This member is clinically asymptomatic. Pen-
tagastrin test resutts show CT levels of 0.02 p,g/L basal and 0.03 
fjLg/L at two minutes. Blood has been taken for DNA analysis. 
Case III-7; This 25-year-old man has a barely palpable thy-
roid gland and no clinical symptoms. Inifial basal plasma CT 
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Figure—Updated pedigree of G-kindred. 
was 0,71 p-g/L; CT remained etevated on subsequent measure-
ments. Although he was initially unwitting to have thyroid sur-
gery, total thyroidectomy done in 1988 showed multiple smalt 
foci of MTC, several C-cell adenomas, and a large parathyroid 
adenoma within the right lobe of the gland. He remains well 
with normal calcium and CT tevels postoperatively. Computed 
tomography of the adrenals has shown bilateral nodules consis-
tent with pheochromocytomas. Plasma and urinary cate-
cholamines remain normal. Adrenal surgery is cunentiy under 
consideration. Blood has been taken for DNA analysis. 
Cases IV-5 and IV-6; Blood has been taken for DNA anatysis. 
Basal CT levels are marginally elevated. 
Remainder of generation IV cases; Basal CT levels remain 
unchanged. Atl members under 18 years of age have been 
screened only for basal CT levels. Pentagastrin testing has not 
been attempted, and blood has not been taken for DNA analysis. 
Discussion 
Between 1965 and 1986, 25 cases of MTC were diagnosed 
histologically in Northem Ireland. Seven of these are from the 
G-kindred. The remainder have not yet shown any hereditary 
tendency. 
Although we attempted to bring family members together for 
same-day counseling and screening, we leamed that this was in-
appropriate and inadvisable because of various family member 
interactions and the reasonable desire for personal discussion. 
Each member has subsequentiy been seen by one of us (PJM) on 
a one-to-one basis, usually in the patient's home. This has al-
lowed the patients to discuss their problems and fear of the dis-
ease and has allowed DNA sampling from virtually all the pa-
tients over age 18. If the patients do not allow counseling and 
screening for their own diagnosis, permission has been obtained 
for the results to be used to help other members of the pedigree. 
Since the ethical guidelines for screening patients under age 
18 are uncertain, we have not taken blood for DNA from most 
patients in generation IV; only two patients were studied with 
their parents' consent. This approach may change with either 
clinical concem or from changes in guidelines regarding screen-
ing of minors. 
Some patients have declined pentagastrin testing but con-
sented to DNA testing. The rationale is that pentagastrin testing 
is "invasive," ie, it involves injection of a foreign substance 
with uncomfortable but limited side effects, whereas gene test-
ing is neither physically harmful nor invasive. 
Easton et al (5) have suggested that there is an earlier onset of 
MTC in females and a tendency for pheochromocytoma to clus-
ter in families. Our pedigree does not support the first hypoth-
esis; most of our family members presented at about the same 
age. The pedigree does, however, show clustering of pheo-
chromocytomas in two branches. The pedigree in general shows 
that the gene is highly penetrant in character but with a variable 
expressivity; no individuals diagnosed with MTC have shown 
symptoms. 
We still do not know in whom the mutant gene originated. 
Patient I-1 was reputed to have a sister who died having had "thy-
roid trouble." Current genetic tracing using the RBP3, MCK2, 
and plO alpha centromere probes may help either to confine or 
broaden the existing pedigree. 
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